Overview

A Study to Assess the Safety and Efficacy of 7 Days Treatment With a Novel Analgesic in Subjects With Peripheral Neuropathic Pain

Status:
Terminated
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to determine whether a novel analgesic is effective in treating of neuropathic pain caused by herpetic infection, surgery, or trauma.
Phase:
Phase 2
Details
Lead Sponsor:
Grünenthal GmbH
Treatments:
Pregabalin